NEW YORK (360Dx) – T2 Biosystems announced today that it has received a grant worth up to $2 million by CARB-X in order to accelerate the development of new tests to identify bacterial pathogens and resistance markers. The new tests will increase the T2Dx instrument product line by detecting 20 additional bacterial species and resistance targets in whole blood samples, with a focus on blood-borne pathogens on the US Centers for Disease Control and Prevention's antibiotic resistance threat list.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 

Mar
19

In this webinar, Dr. Matthew Faron, a pathologist from the Medical College of Wisconsin, will share results of a comparison study of three rapid influenza assays.

 

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.